US Stock MarketDetailed Quotes

CervoMed (CRVO)

Watchlist
  • 7.080
  • +0.090+1.29%
Close Jan 15 16:00 ET
  • 7.080
  • 0.0000.00%
Post 16:10 ET
65.51MMarket Cap-2.44P/E (TTM)

CervoMed (CRVO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
49.07%8.04M
120.90%6.62M
104.35%5.3M
133.30%18.23M
191.92%7.24M
101.72%5.4M
143.31%3M
81.93%2.59M
124.80%7.81M
164.21%2.48M
Selling and administrative expenses
5.22%2.33M
30.01%3.27M
11.97%2.38M
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
112.60%2.13M
204.77%6.52M
279.06%2.12M
-General and administrative expense
5.22%2.33M
30.01%3.27M
11.97%2.38M
40.61%9.17M
9.48%2.32M
-8.27%2.21M
153.05%2.51M
112.60%2.13M
204.77%6.52M
279.06%2.12M
Research and development costs
17.86%6.04M
35.42%5.11M
71.90%4.84M
122.77%18.8M
148.19%7.09M
186.08%5.13M
92.63%3.77M
53.51%2.81M
531.40%8.44M
650.06%2.86M
Other operating expenses
83.37%-322.57K
46.56%-1.76M
18.31%-1.92M
-36.29%-9.74M
13.19%-2.16M
-27.07%-1.94M
-91.23%-3.29M
-66.72%-2.35M
---7.14M
---2.49M
Operating profit
-49.07%-8.04M
-120.90%-6.62M
-104.35%-5.3M
-133.30%-18.23M
-191.92%-7.24M
-101.72%-5.4M
-143.31%-3M
-81.93%-2.59M
-124.80%-7.81M
-164.21%-2.48M
Net non-operating interest income expense
-50.67%318.79K
-45.74%368.13K
407.22%408.99K
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
127.75%80.63K
255.99%219.43K
276.89%118.65K
Non-operating interest income
-50.67%318.79K
-45.74%368.13K
407.22%408.99K
782.94%1.94M
348.52%532.18K
1,255.60%646.17K
3,731.48%678.44K
127.75%80.63K
252.63%219.43K
269.99%118.65K
Other net income (expense)
64.33%-1.23K
-4,052.23%-10.26K
-350.00%-135
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
-100.00%-30
326.93%5.42M
99.90%-600
Other non- operating income (expenses)
64.33%-1.23K
-4,052.23%-10.26K
-350.00%-135
-100.02%-991
554.33%2.73K
-100.07%-3.44K
99.88%-247
-100.00%-30
326.93%5.42M
99.90%-600
Income before tax
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
Income tax
Net income
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
Net income continuous Operations
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
Minority interest income
Net income attributable to the parent company
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-62.54%-7.73M
-170.12%-6.26M
-94.65%-4.89M
-650.08%-16.29M
-183.86%-6.71M
-321.06%-4.75M
-62.53%-2.32M
-370.55%-2.51M
62.57%-2.17M
-54.67%-2.36M
Basic earnings per share
-52.73%-0.84
-159.26%-0.7
-36.59%-0.56
-146.34%-2.02
-92.16%-0.8
-184.62%-0.55
90.18%-0.27
60.19%-0.41
92.68%-0.82
85.89%-0.4163
Diluted earnings per share
-52.73%-0.84
-159.26%-0.7
-36.59%-0.56
-146.34%-2.02
-92.16%-0.8
21.43%-0.55
90.18%-0.27
60.19%-0.41
92.68%-0.82
85.89%-0.4163
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 49.07%8.04M120.90%6.62M104.35%5.3M133.30%18.23M191.92%7.24M101.72%5.4M143.31%3M81.93%2.59M124.80%7.81M164.21%2.48M
Selling and administrative expenses 5.22%2.33M30.01%3.27M11.97%2.38M40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M112.60%2.13M204.77%6.52M279.06%2.12M
-General and administrative expense 5.22%2.33M30.01%3.27M11.97%2.38M40.61%9.17M9.48%2.32M-8.27%2.21M153.05%2.51M112.60%2.13M204.77%6.52M279.06%2.12M
Research and development costs 17.86%6.04M35.42%5.11M71.90%4.84M122.77%18.8M148.19%7.09M186.08%5.13M92.63%3.77M53.51%2.81M531.40%8.44M650.06%2.86M
Other operating expenses 83.37%-322.57K46.56%-1.76M18.31%-1.92M-36.29%-9.74M13.19%-2.16M-27.07%-1.94M-91.23%-3.29M-66.72%-2.35M---7.14M---2.49M
Operating profit -49.07%-8.04M-120.90%-6.62M-104.35%-5.3M-133.30%-18.23M-191.92%-7.24M-101.72%-5.4M-143.31%-3M-81.93%-2.59M-124.80%-7.81M-164.21%-2.48M
Net non-operating interest income expense -50.67%318.79K-45.74%368.13K407.22%408.99K782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K127.75%80.63K255.99%219.43K276.89%118.65K
Non-operating interest income -50.67%318.79K-45.74%368.13K407.22%408.99K782.94%1.94M348.52%532.18K1,255.60%646.17K3,731.48%678.44K127.75%80.63K252.63%219.43K269.99%118.65K
Other net income (expense) 64.33%-1.23K-4,052.23%-10.26K-350.00%-135-100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247-100.00%-30326.93%5.42M99.90%-600
Other non- operating income (expenses) 64.33%-1.23K-4,052.23%-10.26K-350.00%-135-100.02%-991554.33%2.73K-100.07%-3.44K99.88%-247-100.00%-30326.93%5.42M99.90%-600
Income before tax -62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M
Income tax
Net income -62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M
Net income continuous Operations -62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M
Minority interest income
Net income attributable to the parent company -62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -62.54%-7.73M-170.12%-6.26M-94.65%-4.89M-650.08%-16.29M-183.86%-6.71M-321.06%-4.75M-62.53%-2.32M-370.55%-2.51M62.57%-2.17M-54.67%-2.36M
Basic earnings per share -52.73%-0.84-159.26%-0.7-36.59%-0.56-146.34%-2.02-92.16%-0.8-184.62%-0.5590.18%-0.2760.19%-0.4192.68%-0.8285.89%-0.4163
Diluted earnings per share -52.73%-0.84-159.26%-0.7-36.59%-0.56-146.34%-2.02-92.16%-0.821.43%-0.5590.18%-0.2760.19%-0.4192.68%-0.8285.89%-0.4163
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More